Exhibit Hall Theater Talks
Gene-editing in combination with induced pluripotent stem cells (iPSCs) has provided a powerful opportunity to accelerate human disease modelling and drug discovery. However, among geneediting workflows, single-cell cloning remains the most challenging bottleneck according to ~50% of researchers in a recent survey. While existing high-throughput cell sorting and isolation techniques offer the benefit of automated single-cell seeding, they are often too harsh on cells and do not offer comprehensive automation, such as cell feeding and harvesting of clones. iotaSciences’ Cloning Platform XT offers a complete single-cell cloning solution. The system utilizes platform-specific miniature culture chambers, requiring <1 microlitre of culture medium to grow single cells into verified clonal cultures. Ultra-gentle cell and fluid handling maximizes cell viability and achieves market-leading cloning efficiencies, while AI-powered monoclonality assessment and image capture capabilities provide a fully documented workflow.